Gaithersburg’s Novavax says it will have an updated Covid-19 vaccine ready after an FDA committee voted unanimously on the ...
Novavax stock zipped to a nearly two-year high Thursday after the FDA set a potential approval date for its Covid vaccine in ...
OTTAWA - A massive new Toronto vaccine factory, tasked with making flu shots and preparing for the next pandemic, won’t start ...
Shares of vaccine stocks Moderna(NASDAQ: MRNA), Novavax(NASDAQ: NVAX), and BioNTech SE(NASDAQ: BNTX) rallied this week, ...
Anjalee Khemlani is an award-winning healthcare and business reporter at Yahoo Finance covering the entire healthcare sector, including pharma, health tech, providers, insurers, PBMs and health equity ...
Stocks that have been left for dead, or at least seen as dead money, can garner huge profits for investors if they start rising like a Phoenix from the ashes.
Novavax (NASDAQ:NVAX) submitted an application to the FDA, seeking to amend its Emergency Use Authorization (EUA) and update its protein-based COVID-19 vaccine for the upcoming fall season.
Sanofi is offering Belharra Therapeutics up to $700 million in biobucks for a tow out to surf the waves of small molecule drug discovery in immunology. The deal includes $40 million upfront and in ...
Novavax has seen a surge in stock price due to recent COVID-19 and bird flu vaccine developments, reaching over $27 per share. The company is making headlines with updates on their COVID-19 ...
Novavax stock hit a new 52-week high of $23.86 last week, and while it has come down from there in recent days, the stock's price remains at levels it hasn't seen since late 2022. It's not just ...